Trade Summary

1 week ago, Lorrain Daniel S., serving as Chief Scientific Officer at Contineum Therapeutics, Inc. (CTNM), sold 4,170 shares at $12.23 per share, for a total transaction value of $51,009.00. Following this transaction, Lorrain Daniel S. now holds 171,234 shares of CTNM.

This sale represents a 2.00% decrease in Lorrain Daniel S.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, December 23, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 30, 2025, 7 days after the trade was made.